Shanghai HeartCare Medical Technology Corporation Limited Sustainability Profile
Shanghai HeartCare Medical Technology Corporation Limited, commonly referred to as HeartCare, is a leading player in the medical technology industry, headquartered in Shanghai, China. Founded in 2005, the company has established itself as a pioneer in cardiovascular health solutions, focusing on innovative diagnostic and therapeutic devices. HeartCare's core offerings include advanced cardiac monitoring systems and minimally invasive surgical tools, designed to enhance patient outcomes and streamline healthcare processes. The company is recognised for its commitment to quality and innovation, positioning itself as a trusted partner in the medical community. With a strong presence in Asia and expanding operations globally, HeartCare has achieved significant milestones, including numerous patents and collaborations with top-tier medical institutions. Its dedication to advancing heart health technology continues to solidify its market position as a frontrunner in the field.
DitchCarbon Score
How does Shanghai HeartCare Medical Technology Corporation Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai HeartCare Medical Technology Corporation Limited's score of 27 is lower than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shanghai HeartCare Medical Technology Corporation Limited's reported carbon emissions
In 2024, Shanghai HeartCare Medical Technology Corporation Limited reported total carbon emissions of approximately 1,830,000 kg CO2e. This figure includes about 12,400 kg CO2e from Scope 1 emissions and around 1,817,600 kg CO2e from Scope 2 emissions. In the previous year, 2023, the company’s total emissions were about 2,530,000 kg CO2e, with Scope 1 emissions at approximately 7,400 kg CO2e and Scope 2 emissions at about 2,522,600 kg CO2e. Despite these figures, the company has not established any specific reduction targets or climate pledges, indicating a lack of formal commitments to reduce emissions at this time. The absence of Scope 3 emissions data suggests that the company may not be fully accounting for its entire carbon footprint. Shanghai HeartCare Medical Technology Corporation Limited operates independently without cascading emissions data from a parent or related organization. As such, its climate commitments and emissions reporting are solely based on its own operational activities.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 7,400 | 00,000 |
| Scope 2 | 2,522,600 | 0,000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Shanghai HeartCare Medical Technology Corporation Limited's Industry?
How Carbon Intensive is Shanghai HeartCare Medical Technology Corporation Limited's Location?
Shanghai HeartCare Medical Technology Corporation Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shanghai HeartCare Medical Technology Corporation Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
